HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS

Title:

HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS

Document Type and Number:

WIPO Patent Application WO/2017/123884

Kind Code:

A8

Abstract:

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: Formula (I) which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

More Like This:

JP4190750	Clutch structure of automatic transmission
JP2023546527	Novel benzazepine spirocyclic derivatives
JPS6040422	[Title of the Invention] Substitution 1 ‐Al kill thiophenyl 2, 3, and 4, a 5 ―Tetra hydronalium 1H-3 ―Benz azepine compound

Inventors:

YU JIANMING (US)
SHOOK BRIAN C (US)
BLAISDELL THOMAS P (US)
KIM IN JONG (US)
PANARESE JOSEPH (US)
MCGRATH KEVIN (US)
NEGRETTI EMMANUELLI SOLYMAR (US)
OR YAT SUN (US)

Application Number:

PCT/US2017/013357

Publication Date:

February 22, 2018

Filing Date:

January 13, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ENANTA PHARM INC (US)

International Classes:

C07D223/16; C07D495/04

Attorney, Agent or Firm:

HARLAN, Edgar, W. et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: VASCULAR EXTRACELLULAR MATRIX HYDROGEL

Next Patent: COMPOSITE ARTICLE